Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000211728

Medchemexpress LLC Navitoclax (ABT-263) | 923564-51-6 | MFCD12756219 | ≥98.0% | 974.61 g·mol⁻¹ | C47H55ClF3N5O6S3 | 200 MG
SDP

Supplier:  Medchemexpress LLC HY10087200MG

Encompass_Preferred

Navitoclax (ABT-263) is a potent, orally active small-molecule inhibitor of anti-apoptotic Bcl-2 family proteins used in preclinical apoptosis and oncology research. Supplied as a powder, it is used for both in vitro assays and in vivo models, with documented solubility and recommended storage for stability.

  • Potent Bcl-2 family inhibitor for apoptosis research.
  • Orally active small molecule suitable for in vivo studies.
  • High solubility in DMSO for convenient stock solutions.
  • Available in multiple quantities for dosing flexibility.
  • Recommended storage conditions to preserve stability.

Catalog No. 50-002-11728


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.